BMS-986016 Uses, Dosage, Side Effects and more
BMS-986016 is under investigation in clinical trial NCT02966548 (Safety Study of BMS-986016 With or Without Nivolumab in Patients With Advanced Solid Tumors).
| Attribute | Details |
|---|---|
| Trade Name | BMS-986016 |
| Generic | Relatlimab |
| Relatlimab Other Names | BMS-986016, Relatlimab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
